Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Organon & Co.

< Previous 1 2 3 Next >
Samsung Bioepis and Organon Announce FDA Approval of Citrate-Free High-Concentration HUMIRA® Biosimilar HADLIMA™ (adalimumab-bwwd)
From Organon & Co.
Via Business Wire
Tickers OGN
Organon Reports Results for the Second Quarter Ended June 30, 2022
From Organon & Co.
Via Business Wire
Tickers OGN
Organon and Cirqle Biomedical Enter Research Collaboration and License Agreement for Investigational Non-hormonal, On-demand Contraceptive Candidate
From Organon & Co.
Via Business Wire
Tickers OGN
Organon To Report Second Quarter Results and Host Conference Call on August 4, 2022
From Organon & Co.
Via Business Wire
Tickers OGN
Organon Enters into Global License Agreement to Commercialize Henlius’ Investigational Perjeta® (Pertuzumab) and Prolia®/Xgeva® (Denosumab) Biosimilar Candidates
From Organon & Co.
Via Business Wire
Tickers OGN
On One Year Anniversary, Organon Introduces Global ESG Strategy and Commitments with Publication of Inaugural ESG Report
From Organon & Co.
Via Business Wire
Tickers OGN
Organon Reports Results for the First Quarter Ended March 31, 2022
From Organon & Co.
Via Business Wire
Tickers OGN
Organon To Report First Quarter Results and Host Conference Call on May 5, 2022
From Organon & Co.
Via Business Wire
Tickers OGN
Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis (BV)
From Organon & Co.
Via Business Wire
Tickers DARE OGN
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2021
From Organon & Co.
Via Business Wire
Tickers OGN
Organon Acquires Contraceptive Products, Marvelon® and Mercilon®, in the People’s Republic of China, including Hong Kong and Macau, and Agrees to Acquire these Products in Vietnam
From Organon & Co.
Via Business Wire
Tickers OGN
Organon Declares Paid Time Off for All Employees on International Women’s Day; Employees to Focus on Their Own Health in Recognition of Growing Women’s Health Inequity
From Organon & Co.
Via Business Wire
Tickers OGN
Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 17, 2022
From Organon & Co.
Via Business Wire
Tickers OGN
FDA Accepts Samsung Bioepis’ and Organon’s sBLA for their Citrate-Free, High-Concentration HUMIRA® (Adalimumab) Biosimilar Candidate
From Organon & Co.
Via Business Wire
Tickers OGN
Organon To Present at the 40th Annual J.P. Morgan Healthcare Virtual Conference
From Organon & Co.
Via Business Wire
Tickers OGN
Organon Completes Acquisition of Forendo Pharma
From Organon & Co.
Via Business Wire
Tickers OGN
Organon To Present at the Evercore ISI 4th Annual HealthCONx Conference
From Organon & Co.
Via Business Wire
Tickers OGN
Organon Reports Results for the Third Quarter Ended September 30, 2021
From Organon & Co.
Via Business Wire
Tickers OGN
Organon to Acquire Forendo Pharma
From Organon & Co.
Via Business Wire
Tickers OGN
Organon To Report Third Quarter Results and Host Conference Call on November 11, 2021
From Organon & Co.
Via Business Wire
Tickers OGN
Organon Launches New Fertility Journey Website as Part of Ongoing Commitment to Help Address the Needs of Women
From Organon & Co.
Via Business Wire
Tickers OGN
Organon Receives FDA Clearance for Technological Updates to the Jada® System, a Medical Device Intended to Control Postpartum Hemorrhage
From Organon & Co.
Via Business Wire
Tickers OGN
Organon Aims to Ignite Worldwide Conversation Around Unplanned Pregnancy
From Organon & Co.
Via Business Wire
Tickers OGN
Organon To Present at Morgan Stanley’s 19th Annual Global Healthcare Virtual Conference
From Organon & Co.
Via Business Wire
Tickers OGN
Organon To Present at Citi’s 16th Annual BioPharma Virtual Conference
From Organon & Co.
Via Business Wire
Tickers OGN
Organon Reports Results for the Second Quarter Ended June 30, 2021 and Announces Inaugural Dividend
From Organon & Co.
Via Business Wire
Tickers OGN
Organon To Report Fiscal Q2 Results and Host Conference Call on August 12, 2021
From Organon & Co.
Via Business Wire
Tickers OGN
Organon Recommends Stockholders Reject Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
From Organon & Co.
Via Business Wire
Tickers OGN
Organon Announces Filing of Form 10-Q for the Quarter Ended March 31, 2021
From Organon & Co.
Via Business Wire
Tickers OGN
Organon Completes Acquisition of Alydia Health – A Medical Device Company Focused on Postpartum Hemorrhage
From Organon & Co.
Via Business Wire
Tickers OGN
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback